Tenax Therapeutics has secured global rights to oral and subcutaneous (under the skin) formulations of levosimendan, a potential therapy…
Articles by Andrea Lobo
People with pulmonary hypertension (PH) and high blood acetylcholine (ACh) levels show more severe symptoms and…
The first healthy volunteer has been dosed in a Phase 1 trial testing ZMA001, Zymedi’s first-in-class investigational therapy for…
Access to pulmonary rehabilitation programs for people with pulmonary hypertension (PH) and other chronic respiratory conditions is considerably more…
The U.S. Food and Drug Administration (FDA) has approved Cereno Scientific’s investigational drug CS1 in an…
Atrial fibrillation or AF — a heart condition marked by an irregular heartbeat — is associated with longer hospital stays,…
When choosing a treatment regimen, people with pulmonary arterial hypertension (PAH) consider the impact on physical limitations and survival…
Treating children with Revatio (sildenafil) reduced pulmonary arterial pressure after surgery for congenital heart disease (CHD), according to a…
The ARRDC3 gene — implicated in inflammation and cell growth — may be a ferroptosis-related biomarker and treatment target in…
Corsair Pharma has secured $23 million in financing to support clinical testing of a skin patch for the…
A joint initiative between a Singapore-based medical technology company and Duke University is aiming to develop and commercialize artificial intelligence,…
Gradient Denervation Technologies has raised €14 million (around $14.9 million) in funding to support the clinical development and testing…